Guinea has reached a transformative milestone in its public health journey with the official introduction of the RTS,S malaria vaccine into its national immunization program. This groundbreaking initiative, launched in August 2025, targets four districts, Mamou, Gaoual, Kankan, and Yomou, where malaria prevalence remains alarmingly high. Approximately 60,000 children aged between five and eleven months are expected to receive the vaccine annually, offering a vital layer of protection against one of the country’s most persistent and deadly diseases.
Malaria continues to be the leading cause of illness and death among children under five in Guinea, accounting for more than a third of pediatric hospital visits and fatalities. In 2023 alone, the country recorded an estimated 4.43 million malaria cases, with parasite prevalence exceeding 30 percent in several regions. The RTS,S vaccine, which requires four doses for maximum efficacy, is designed to work alongside existing preventive measures such as insecticide-treated bed nets and antimalarial treatments. Its integration into routine immunization represents a strategic effort to reduce hospitalizations, improve child survival rates, and ease the burden on the healthcare system.
The rollout is supported by a coalition of global health organizations, including Gavi, the Vaccine Alliance, the World Health Organization, UNICEF, and PATH. Guinea’s Health Minister, Dr. Oumar Diouhé Bah, described the initiative as “an act of health justice,” underscoring the government’s commitment to equity and the right of every child to begin life protected from preventable diseases. The vaccine is being provided free of charge, and extensive outreach campaigns are underway to educate families, mobilize communities, and encourage widespread participation. Local health workers and community leaders are playing a central role in building trust and ensuring that no child is left behind.
With this move, Guinea joins a growing coalition of 21 African nations that have adopted the malaria vaccine into their national immunization schedules. The collective momentum reflects a regional determination to combat malaria through science, solidarity, and sustained investment in public health infrastructure. While challenges remain in terms of logistics, vaccine coverage, and community engagement, the introduction of RTS,S marks a hopeful turning point. For many families, it represents not just a medical intervention, but a promise of a healthier future for the next generation.